Term Name: EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor
Synonyms: 3beta (or 20alpha)-hydroxysteroid dehydrogenase inhibitor, 3beta (or 20alpha)-hydroxysteroid dehydrogenase inhibitors, 3beta(or 20alpha)-hydroxysteroid dehydrogenase (EC 1.1.1.210) inhibitor, 3beta(or 20alpha)-hydroxysteroid dehydrogenase (EC 1.1.1.210) inhibitors, 3beta(or 20alpha)-hydroxysteroid dehydrogenase inhibitor, 3beta(or 20alpha)-hydroxysteroid dehydrogenase inhibitors, 3beta(or 20alpha)-hydroxysteroid:NADP(+) oxidoreductase inhibitor, 3beta(or 20alpha)-hydroxysteroid:NADP(+) oxidoreductase inhibitors, 3beta,20alpha-hydroxysteroid oxidoreductase inhibitor, 3beta,20alpha-hydroxysteroid oxidoreductase inhibitors, 3beta-HSD, 3beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase inhibitor, dehydrogenase, 3beta,20alpha-hydroxy steroid inhibitor, dehydrogenase, 3beta,20alpha-hydroxy steroid inhibitors, EC 1.1.1.210 (3beta(or 20alpha)-hydroxysteroid dehydrogenase) inhibitor, EC 1.1.1.210 (3beta(or 20alpha)-hydroxysteroid dehydrogenase) inhibitors, EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitors, EC 1.1.1.210 inhibitor, EC 1.1.1.210 inhibitors, progesterone reductase inhibitor, progesterone reductase inhibitors
Definition: An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor which interferes with the action of 3beta-hydroxysteroid dehydrogenase (EC 1.1.1.210), a group of steroidogenic enzymes.
Ontology: ChEBI [CHEBI:50788]  ( EBI )

Relationships
is a type of: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
inverse has_role: trilostane